Quarterly Call Option Transactions in Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI) during . The information is specifically focused on institutions that hold call options of Denali Therapeutics Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 8,000 | 0 | 8,000 | 95,300 | 0 | 95,300 | -87,300 | |
| Q4 2021 | — | 181,400 | 0 | 181,400 | -181,400 | |||
| Q1 2022 | 600 | 0 | 600 | 0 | 30,000 | 30,000 | -29,400 | |
| Q2 2022 | 8,200 | 5,000 | 13,200 | — | 13,200 | |||
| Q3 2022 | 22,400 | 26,400 | 48,800 | 4,400 | 0 | 4,400 | 44,400 | |
| Q4 2022 | 10,700 | 0 | 10,700 | 16,900 | 0 | 16,900 | -6,200 | |
| Q1 2023 | — | 16,500 | 0 | 16,500 | -16,500 | |||
| Q2 2023 | — | 18,600 | 0 | 18,600 | -18,600 | |||
| Q3 2023 | 8,800 | 50,000 | 58,800 | 100 | 0 | 100 | 58,700 | |
| Q4 2023 | 0 | 24,100 | 24,100 | 17,500 | 0 | 17,500 | 6,600 | |
| Q1 2024 | 20,300 | 104,600 | 124,900 | — | 124,900 | |||
| Q2 2024 | 0 | 89,900 | 89,900 | 54,800 | 0 | 54,800 | 35,100 | |
| Q3 2024 | 8,400 | 16,100 | 24,500 | 1,100 | 0 | 1,100 | 23,400 | |